<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03245255</url>
  </required_header>
  <id_info>
    <org_study_id>R21HL130899</org_study_id>
    <secondary_id>R21HL130899</secondary_id>
    <nct_id>NCT03245255</nct_id>
  </id_info>
  <brief_title>Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound</brief_title>
  <official_title>Noninvasive Real-time Intracardiac Pressure Measurements Using Subharmonic Ultrasound</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Thomas Jefferson University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>GE Healthcare</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Thomas Jefferson University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will use contrast echocardiography to assess the accuracy of a new non-invasive
      imaging method for subharmonic aided pressure estimation (SHAPE) compared to simultaneously
      acquired intra-cardiac pressures measured invasively during cardiac catheterization. This
      study is designed to verify that contrast echocardiography using the SHAPE method, already
      proven in a canine model and tested in a human pilot study can be used as a surrogate for
      cardiac catheterization with sufficient accuracy to allow clinical applicability in humans.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 4, 2017</start_date>
  <completion_date type="Anticipated">March 31, 2019</completion_date>
  <primary_completion_date type="Anticipated">March 31, 2019</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Agreement between SHAPE and pressure catheter measurements</measure>
    <time_frame>up to 1 day</time_frame>
    <description>Correlation</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Error between SHAPE and pressure catheter measurements</measure>
    <time_frame>up to 1 day</time_frame>
    <description>ANOVA/Post-hoc comparisons</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Accuracy of ventricular relaxation rate and relaxation time constant</measure>
    <time_frame>up to 1 day</time_frame>
    <description>ANOVA/Post-hoc comparisons</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cardiac Catheterization</condition>
  <condition>Blood Pressure</condition>
  <condition>Heart Ventricles</condition>
  <condition>Echocardiography</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Sonazoid for pressure measurements</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>48 µl of Sonazoid microbubbles (GE Healthcare, Oslo, Norway) will be co-infused at a rate of 0.024 µl/kg body weight/minute together with a 0.9% sodium chloride solution infused at a rate of at least 2 ml/min.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Sonazoid</intervention_name>
    <description>Whenever a patient undergoes cardiac catheterization, which routinely includes intracardiac pressure monitoring using a pressure catheter, as part of their standard clinical care and agrees to participate in the study, we will acquire research data. With Sonazoid infusion, SHAPE algorithm will be initiated to determine optimum acoustic pressure. Then, at the optimum acoustic pressure, SHAPE specific data will be acquired from the cardiac chambers and aorta synchronously with the pressures recorded by the catheter (as a part of the patient's standard of care). After acquiring the ultrasound imaging data, the remainder of the heart catheterization will be completed by the attending cardiologist according to the patients' standard of care.</description>
    <arm_group_label>Sonazoid for pressure measurements</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Be scheduled for cardiac catheterization procedure.

          -  Be at least 18 years of age.

          -  Be medically stable.

          -  If a female of child-bearing potential, must have a negative pregnancy test.

          -  Be conscious and able to comply with study procedures.

          -  Have signed Informed Consent to participate in the study.

        Exclusion Criteria:

          -  Clinically unstable patients, e.g., those who are clinically in decompensated heart
             failure or having active chest pain or presenting for admission with an unstable
             anginal syndrome

          -  Patients in whom introduction of a catheter into the left ventricle is contraindicated
             or would potentially be dangerous, e.g., patients with active ventricular arrhythmias
             or with significant aortic valve stenosis where crossing the aortic valve may be
             difficult and not clinically necessary

          -  Females who are pregnant or nursing.

          -  Patients not scheduled for cardiac catheterization procedure.

          -  Patients who have received an investigational drug in the 30 days before, or will
             receive one within 72 h after, study drug administration.

          -  Patients currently on chemotherapy or with other primary cancers requiring treatment.

          -  Patients who are medically unstable, patients who are seriously or terminally ill, and
             patients whose clinical course is unpredictable.

          -  Patients with a history of anaphylactic allergy to eggs or egg products, manifested by
             one or more of the following symptoms: generalised urticaria, difficulty in breathing,
             swelling of the mouth and throat, hypotension, or shock. (Subjects with
             nonanaphylactic allergies to eggs or egg products may be enrolled in the study, but
             must be watched carefully for 1 h following the administration of SONAZOID).

          -  Patients with congenital heart defects.

          -  Patients with severe emphysema, pulmonary vasculitis, or a history of pulmonary
             emboli.

          -  Patients with respiratory distress syndrome or a contraindication to pharmacological
             vasodilator stress agents.

          -  Patients with thrombosis within the hepatic, portal, or mesenteric veins.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jaydev K Dave</last_name>
    <role>Principal Investigator</role>
    <affiliation>Thomas Jefferson University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jaydev K Dave</last_name>
    <phone>2159554806</phone>
    <email>jaydev.dave@jefferson.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Flemming Forsberg</last_name>
    <phone>2159554870</phone>
    <email>flemming.forsberg@jefferson.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Thomas Jefferson University and Thomas Jefferson University Hospital</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19107</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaydev K Dave, PHD</last_name>
      <phone>215-955-4806</phone>
      <email>jaydev.dave@jefferson.edu</email>
    </contact>
    <contact_backup>
      <last_name>Flemming Forsberg, PHD</last_name>
      <phone>2159554870</phone>
      <email>flemming.forsberg@jefferson.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Ira S Cohen, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Savage, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Praveen Mehrotra, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Liu JB, McDonald ME, Dickie K, Leung C, Forsberg F. Noninvasive estimation of dynamic pressures in vitro and in vivo using the subharmonic response from microbubbles. IEEE Trans Ultrason Ferroelectr Freq Control. 2011 Oct;58(10):2056-66. doi: 10.1109/TUFFC.2011.2056.</citation>
    <PMID>21989870</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Forsberg F. Processing of subharmonic signals from ultrasound contrast agents to determine ambient pressures. Ultrason Imaging. 2012 Apr;34(2):81-92.</citation>
    <PMID>22724314</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Merton DA, Liu JB, Machado P, Zhao H, Park S, Dianis S, Chalek CL, Thomenius KE, Brown DB, Forsberg F. On the implementation of an automated acoustic output optimization algorithm for subharmonic aided pressure estimation. Ultrasonics. 2013 Apr;53(4):880-8. doi: 10.1016/j.ultras.2012.12.010. Epub 2013 Jan 2.</citation>
    <PMID>23347593</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Subharmonic microbubble emissions for noninvasively tracking right ventricular pressures. Am J Physiol Heart Circ Physiol. 2012 Jul;303(1):H126-32. doi: 10.1152/ajpheart.00560.2011. Epub 2012 May 4.</citation>
    <PMID>22561300</PMID>
  </reference>
  <reference>
    <citation>Dave JK, Halldorsdottir VG, Eisenbrey JR, Raichlen JS, Liu JB, McDonald ME, Dickie K, Wang S, Leung C, Forsberg F. Noninvasive LV pressure estimation using subharmonic emissions from microbubbles. JACC Cardiovasc Imaging. 2012 Jan;5(1):87-92. doi: 10.1016/j.jcmg.2011.08.017.</citation>
    <PMID>22239898</PMID>
  </reference>
  <reference>
    <citation>Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, Machado P, Park S, Dianis S, Chalek CL, Kim CE, Baliff JP, Thomenius KE, Brown DB, Navarro V, Forsberg F. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013 Aug;268(2):581-8. doi: 10.1148/radiol.13121769. Epub 2013 Mar 22.</citation>
    <PMID>23525208</PMID>
  </reference>
  <reference>
    <citation>Forsberg F, Liu JB, Shi WT, Furuse J, Shimizu M, Goldberg BB. In vivo pressure estimation using subharmonic contrast microbubble signals: proof of concept. IEEE Trans Ultrason Ferroelectr Freq Control. 2005 Apr;52(4):581-3.</citation>
    <PMID>16060506</PMID>
  </reference>
  <reference>
    <citation>Halldorsdottir VG, Dave JK, Leodore LM, Eisenbrey JR, Park S, Hall AL, Thomenius K, Forsberg F. Subharmonic contrast microbubble signals for noninvasive pressure estimation under static and dynamic flow conditions. Ultrason Imaging. 2011 Jul;33(3):153-64.</citation>
    <PMID>21842580</PMID>
  </reference>
  <reference>
    <citation>Shi WT, Forsberg F, Raichlen JS, Needleman L, Goldberg BB. Pressure dependence of subharmonic signals from contrast microbubbles. Ultrasound Med Biol. 1999 Feb;25(2):275-83.</citation>
    <PMID>10320317</PMID>
  </reference>
  <reference>
    <citation>Halldorsdottir VG, Dave JK, Eisenbrey JR, Machado P, Zhao H, Liu JB, Merton DA, Forsberg F. Subharmonic aided pressure estimation for monitoring interstitial fluid pressure in tumours--in vitro and in vivo proof of concept. Ultrasonics. 2014 Sep;54(7):1938-44. doi: 10.1016/j.ultras.2014.04.022. Epub 2014 May 6.</citation>
    <PMID>24856899</PMID>
  </reference>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 4, 2017</study_first_submitted>
  <study_first_submitted_qc>August 7, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2017</study_first_posted>
  <last_update_submitted>April 26, 2018</last_update_submitted>
  <last_update_submitted_qc>April 26, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>pressure measurements</keyword>
  <keyword>blood pressure</keyword>
  <keyword>contrast echocardiography</keyword>
  <keyword>ventricular pressures</keyword>
  <keyword>catheterization</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>This project will generate pressure values in the aorta, and left and right ventricles using the proposed research method (i.e., SHAPE) and using the standard of care (i.e., catheter based pressure values). Additionally peripheral and central pressures will be generated. All of the pressure values will be made available. Further, all ultrasound data obtained for SHAPE measurements will be made available after anonymizing the data-set to remove any patient information</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

